Ensysce Biosciences Stock Price Prediction
| ENSC Stock | USD 0.55 0.07 14.58% |
Oversold Vs Overbought
63
Oversold | Overbought |
EPS Estimate Next Quarter (0.25) | EPS Estimate Current Year (0.83) | EPS Estimate Next Year (0.68) | Wall Street Target Price 6.8 | EPS Estimate Current Quarter (0.29) |
Using Ensysce Biosciences hype-based prediction, you can estimate the value of Ensysce Biosciences from the perspective of Ensysce Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Ensysce Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Ensysce because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ensysce Biosciences after-hype prediction price | USD 0.51 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Ensysce |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ensysce Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ensysce Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Ensysce Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ensysce Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ensysce Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ensysce Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Ensysce Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ensysce Biosciences' historical news coverage. Ensysce Biosciences' after-hype downside and upside margins for the prediction period are 0.03 and 23.65, respectively. We have considered Ensysce Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ensysce Biosciences is abnormally volatile at this time. Analysis and calculation of next after-hype price of Ensysce Biosciences is based on 3 months time horizon.
Ensysce Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Ensysce Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ensysce Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ensysce Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.12 | 23.14 | 0.04 | 0.04 | 5 Events / Month | 3 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.55 | 0.51 | 7.27 |
|
Ensysce Biosciences Hype Timeline
Ensysce Biosciences is currently traded for 0.55. The entity has historical hype elasticity of -0.04, and average elasticity to hype of competition of 0.04. Ensysce is projected to decline in value after the next headline, with the price expected to drop to 0.51. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -7.27%, whereas the daily expected return is currently at 2.12%. The volatility of related hype on Ensysce Biosciences is about 128555.56%, with the expected price after the next announcement by competition of 0.59. About 22.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.22. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ensysce Biosciences recorded a loss per share of 1.94. The entity had not issued any dividends in recent years. The firm had 1:12 split on the 31st of March 2023. Given the investment horizon of 90 days the next projected press release will be in about 5 days. Check out Ensysce Biosciences Basic Forecasting Models to cross-verify your projections.Ensysce Biosciences Related Hype Analysis
Having access to credible news sources related to Ensysce Biosciences' direct competition is more important than ever and may enhance your ability to predict Ensysce Biosciences' future price movements. Getting to know how Ensysce Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ensysce Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.19) | 6.21 | (9.35) | 34.87 | |
| SCPH | Scpharmaceuticals | (0.1) | 7 per month | 0.00 | (0.21) | 4.05 | (7.09) | 20.70 | |
| MIST | Milestone Pharmaceuticals | 0.05 | 7 per month | 1.61 | 0.09 | 7.19 | (2.11) | 18.66 | |
| MCRB | Seres Therapeutics | (0.06) | 9 per month | 5.66 | 0.02 | 10.84 | (9.78) | 28.84 | |
| LUMO | Lumos Pharma | (0.05) | 6 per month | 2.72 | 0.05 | 5.95 | (5.19) | 16.25 |
Ensysce Biosciences Additional Predictive Modules
Most predictive techniques to examine Ensysce price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ensysce using various technical indicators. When you analyze Ensysce charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ensysce Biosciences Predictive Indicators
The successful prediction of Ensysce Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ensysce Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ensysce Biosciences based on analysis of Ensysce Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ensysce Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ensysce Biosciences's related companies. | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.56 | 0.65 | 0.62 | Price To Sales Ratio | 0.64 | 1.08 | 1.02 |
Story Coverage note for Ensysce Biosciences
The number of cover stories for Ensysce Biosciences depends on current market conditions and Ensysce Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ensysce Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ensysce Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Ensysce Biosciences Short Properties
Ensysce Biosciences' future price predictability will typically decrease when Ensysce Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ensysce Biosciences often depends not only on the future outlook of the potential Ensysce Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ensysce Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.3 M | |
| Cash And Short Term Investments | 1.1 M |
Complementary Tools for Ensysce Stock analysis
When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |